Revance Therapeutics, Inc. reports

Company location: Nashville, TN
Fiscal year end: 31 December

Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 326-350 of 946 matching filings.

Per page

25

Current page

14

4

FORM 4

Filing date: 10 Nov 2021
Reporting date: 09 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36297

10-Q

Filing date: 09 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 09 Nov 2021
Reporting date: 09 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 15 Oct 2021
Reporting date: 13 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 15 Oct 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 28 Sep 2021
Reporting date: 27 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Aug 2021
Reporting date: 15 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36297

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 05 Aug 2021
Reporting date: 05 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jul 2021
Reporting date: 28 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 28 Jul 2021
Reporting date: 26 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 06 Jul 2021
Reporting date: 01 Jul 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 02 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 26 May 2021
Reporting date: 26 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36297

10-Q

Filing date: 10 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36297

8-K

Filing date: 10 May 2021
Reporting date: 10 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 May 2021
Reporting date: 05 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .